5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis
Clinical trial NCT00120523 · COMPLETED
Trial details
- NCT number
- NCT00120523
- Sponsor
- MEDA Pharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2010-10-01
- Enrollment
- 2418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.